首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparison and Evaluation of Real-Time PCR Real-Time Nucleic Acid Sequence-Based Amplification Conventional PCR and Serology for Diagnosis of Mycoplasma pneumoniae
【2h】

Comparison and Evaluation of Real-Time PCR Real-Time Nucleic Acid Sequence-Based Amplification Conventional PCR and Serology for Diagnosis of Mycoplasma pneumoniae

机译:实时PCR基于实时核酸序列的扩增常规PCR和血清学诊断肺炎支原体的比较和评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycoplasma pneumoniae is a common cause of community-acquired pneumonia and lower-respiratory-tract infections. Diagnosis has traditionally been obtained by serological diagnosis, but increasingly, molecular techniques have been applied. However, the number of studies actually comparing these assays is limited. The development of a novel duplex real-time PCR assay for detection of M. pneumoniae in the presence of an internal control real-time PCR is described. In addition, real-time nucleic acid sequence-based amplification (NASBA) on an iCycler apparatus is evaluated. These assays were compared to serology and a conventional PCR assay for 106 clinical samples from patients with lower-respiratory-tract infection. Of the 106 samples, 12 (11.3%) were positive by all the molecular methods whereas serology with acute sample and convalescent samples detected 6 (5.6%) and 9 (8.5%), respectively. Clinical symptoms of the patients with Mycoplasma-positive results were compared to those of the other patients with lower-respiratory-tract infections, and it was found that the results for mean lower age numbers as well as the presence of chills, increased erythrocyte sedimentation rate, and raised C-reactive protein levels showed significant differences. Molecular methods are superior for diagnosis of M. pneumoniae, providing more timely diagnosis. In addition, using real-time methods involves less hands-on time and affords the ability to monitor the reaction in the same tube.
机译:肺炎支原体是社区获得性肺炎和下呼吸道感染的常见原因。传统上通过血清学诊断来进行诊断,但是越来越多地应用了分子技术。但是,实际比较这些测定的研究数量有限。描述了开发一种新型的双重实时PCR检测方法,用于在内部对照实时PCR存在的情况下检测肺炎支原体。此外,还评估了iCycler仪器上基于实时核酸序列的扩增(NASBA)。将这些测定与血清学和常规PCR测定进行了比较,对来自下呼吸道感染患者的106份临床样品进行了测定。在所有的分子方法中,在106个样本中,有12个(11.3%)呈阳性,而急性样本和恢复期样本的血清学检测分别为6(5.6%)和9(8.5%)。将支原体阳性结果患者的临床症状与其他下呼吸道感染患者的临床症状进行了比较,发现结果表明年龄平均降低,发冷,红细胞沉降率增加,并且升高的C反应蛋白水平显示出显着差异。分子方法对于肺炎支原体的诊断是优越的,可提供更及时的诊断。此外,使用实时方法需要较少的动手时间,并能够监视同一管中的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号